candesartan has been researched along with azilsartan in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imamiya, E; Inada, Y; Kohara, Y; Kubo, K; Naka, T; Wada, T | 1 |
| Giridhar, R; Murumkar, P; Naik, P; Yadav, MR | 1 |
| Bischoff-Kont, I; Fürst, R; Heering, J; Hernandez-Olmos, V; Kaps, A; Liu, T; Proschak, E; Rajkumar, R; Steinhilber, D | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chen, R; Horiuchi, M; Imura, Y; Iwai, M | 1 |
| Karnik, SS; Matsuo, Y; Miura, S; Okabe, A; Saku, K | 1 |
| Azuma, K; Azushima, K; Kanaoka, T; Maeda, A; Ohsawa, M; Tamura, K; Tsurumi-Ikeya, Y; Umemura, S; Uneda, K; Wakui, H | 1 |
| Enya, K; Igeta, M; Ikeda, Y; Kario, K; Rakugi, H | 1 |
| Hayashi, T; Ishii, T; Mori, Y; Nishioka, T; Nose, K; Saito, Y; Uemura, H; Yasuda, M | 1 |
| Hirooka, Y; Isegawa, K; Kishi, T; Sunagawa, K; Utsumi, H; Yasukawa, K | 1 |
| Enya, K; Ikeda, Y; Kario, K; Rakugi, H; Sugiura, K | 1 |
| Ecelbarger, CM; Hamano, T; Hatanaka, M; Isaka, Y; Kaimori, JY; Matsui, I; Rakugi, H; Takabatake, Y; Takahara, S; Yamamoto, S | 1 |
| Asayama, K; Haga, T; Hosaka, M; Imai, Y; Inoue, R; Kikuya, M; Mano, N; Metoki, H; Murakami, T; Obara, T; Ohkubo, T; Satoh, M | 1 |
| Abe, Y; Ajioka, M; Anzai, T; Aonuma, K; Asakura, M; Hamasaki, T; Hayashi, T; Hiramitsu, S; Kawai, H; Kimura, K; Kioka, H; Kitakaze, M; Lim, YJ; Matsuoka, K; Motoki, H; Nagata, Y; Nakamura, S; Ohte, N; Ozaki, Y; Sasaoka, T; Takahama, H; Tamaki, S | 1 |
| Eriguchi, M; Fujisaki, K; Kitazono, T; Nakano, T; Suehiro, T; Tanaka, S; Torisu, K; Tsuchimoto, A; Tsujikawa, H; Tsuruya, K; Yamada, S; Yoshida, H | 1 |
1 review(s) available for candesartan and azilsartan
| Article | Year |
|---|---|
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan | 2010 |
4 trial(s) available for candesartan and azilsartan
| Article | Year |
|---|---|
Effect of azilsartan versus candesartan on nocturnal blood pressure variation in Japanese patients with essential hypertension.
Topics: Aged; Antihypertensive Agents; Asian People; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Circadian Rhythm; Double-Blind Method; Female; Humans; Hypertension; Japan; Male; Middle Aged; Oxadiazoles; Tetrazoles | 2013 |
Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension.
Topics: Aged; Antihypertensive Agents; Asian People; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Essential Hypertension; Female; Humans; Hypertension; Japan; Male; Middle Aged; Oxadiazoles; Tetrazoles | 2014 |
Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Diastole; Female; Heart Failure; Humans; Hypertension; Japan; Male; Middle Aged; Multicenter Studies as Topic; Oxadiazoles; Randomized Controlled Trials as Topic; Recovery of Function; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Vascular Stiffness; Ventricular Dysfunction, Left; Ventricular Function, Left; Young Adult | 2018 |
Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Female; Humans; Male; Middle Aged; Oxadiazoles; Proteinuria; Renal Insufficiency, Chronic; Tetrazoles | 2021 |
10 other study(ies) available for candesartan and azilsartan
| Article | Year |
|---|---|
Synthesis and angiotensin II receptor antagonistic activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazole bioisosteres.
Topics: Angiotensin Receptor Antagonists; Benzimidazoles; Magnetic Resonance Spectroscopy; Spectrophotometry, Infrared | 1996 |
Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual Screening.
Topics: | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation.
Topics: Adipocytes; Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Cell Differentiation; Cell Size; Eating; Glucose; Glucose Intolerance; Insulin Resistance; Male; Mice; Muscle, Skeletal; Oxadiazoles; Tetrazoles; Tumor Necrosis Factor-alpha | 2007 |
Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chlorocebus aethiops; COS Cells; Humans; Inositol Phosphates; Oxadiazoles; Protein Binding; Receptor, Angiotensin, Type 1; Tetrazoles | 2013 |
What can we expect from the binding characteristics of azilsartan, a newly available angiotensin II blocker, in hypertension?
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Humans; Oxadiazoles; Receptor, Angiotensin, Type 1; Tetrazoles | 2013 |
Examination of the effect of changing to azilsartan from candesartan in renal transplant patients.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Creatinine; Female; Humans; Kidney Transplantation; Male; Oxadiazoles; Tetrazoles | 2014 |
Benefit of azilsartan on blood pressure elevation around rest-to-active phase in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Hypertension; Male; Oxadiazoles; Rats; Rats, Inbred SHR; Rest; Tetrazoles | 2015 |
Azilsartan Improves Salt Sensitivity by Modulating the Proximal Tubular Na+-H+ Exchanger-3 in Mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Nephrectomy; Oxadiazoles; Salt Tolerance; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium, Dietary; Tetrazoles | 2016 |
The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Oxadiazoles; Self Care; Telmisartan; Tetrazoles; Time Factors; Valsartan | 2016 |